
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
In this episode, Suzanne Soliman, PharmD, BCMAS, answered listeners' most frequently asked questions.
In the latest episode, Suzanne Soliman, PharmD, BCMAS, answered frequently asked questions from listeners.






